Please login to read the full text of the article.
If you have no account yet, please register now.
Posted on
Previous Article
« Once-weekly insulin is a promising treatment option Next Article
Shared pathways for COVID-19 and diabetes? »
« Once-weekly insulin is a promising treatment option Next Article
Shared pathways for COVID-19 and diabetes? »
Related Articles
February 4, 2020
Sustained efficacy of monotherapy with upadacitinib after 48 weeks
December 1, 2022
High retention rates after switching between infliximab biosimilars
© 2021 Medicom Medical Publishers. All rights reserved. Terms and Conditions | Privacy Policy